Categories Finance

Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit

Post Content

More From Author

Leave a Reply

Your email address will not be published. Required fields are marked *